Picture of Indivior logo

INDV Indivior News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

REG - Indivior PLC - Transaction in Own Shares

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241029:nRSc9020Ja&default-theme=true

RNS Number : 9020J  Indivior PLC  29 October 2024

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

October 29, 2024

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total
of 324,159 of its ordinary shares of $0.50 each through Morgan Stanley &
Co. International Plc in the period from October 21, 2024, up to and including
October 25, 2024, in connection with its $100m Share Repurchase Program.
Aggregated information on the purchase of these shares can be found in the
table below.

Following the purchase and cancellation of the above shares (including those
purchased but not yet settled), Indivior has 127,883,551 ordinary shares of
$0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (127,883,551) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or a change
to their interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is
defined in the rules of the London Stock Exchange) and "on market" for the
purposes of the Companies Act 2006.

Aggregated information

 Trading Date  Trading Venue  Aggregated daily volume (number of shares)  Daily weighted average purchase price of the shares (p)
 21/10/2024    LSE            14,350                                      645.70
 22/10/2024    LSE            57,681                                      651.74
 22/10/2024    BATE           14,522                                      650.07
 22/10/2024    CHIX           48,049                                      651.27
 22/10/2024    AQUIS          2,942                                       649.98
 23/10/2024    LSE            125,445                                     670.08
 23/10/2024    BATE           1,062                                       673.00
 23/10/2024    CHIX           1,219                                       672.81
 23/10/2024    AQUIS          129                                         673.00
 24/10/2024    LSE            11,143                                      686.45
 25/10/2024    LSE            31,923                                      692.94
 25/10/2024    BATE           4,707                                       692.71
 25/10/2024    CHIX           10,085                                      693.01
 25/10/2024    AQUIS          902                                         693.22

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation
(EU) No 596/2014, as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary shares
made by Morgan Stanley & Co. International Plc on behalf of Indivior
during the above period as part of the Share Repurchase Program can be found
at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program
(http://www.indivior.com/en/investors/shareholder-information/share-repurchase-program)
.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSDZMZGZRMGDZM

Recent news on Indivior

See all news